Literature DB >> 3258201

Natural killer cells in Behçet's disease.

K Hamzaoui1, K Ayed, M Hamza, J L Touraine.   

Abstract

We studied natural killer (NK) cell activity and numbers in the peripheral blood obtained from patients with Behçet's disease (BD) in inactive and convalescent stage, and from healthy controls. Ratios of helper/suppressor cells (OKT4/OKT8) were below 1.0 in patients with active stage and were normal in the convalescent stage of BD. A relative increase of OKT8+ cells and at the same time of Leu 7+ cells was obtained in the active and convalescent BD stages. Double marker analysis revealed that the sub-population of cells expressing both the T8+ and the Leu 7+ antigen (T8+/Leu 7+) was increased in patients with active stage, and normal in the convalescent stage. The frequency of cells reactive with Leu 11 monoclonal antibody (active NK cells) was evaluated in patients with BD. Data from peripheral blood showed an increased sub-population of T8+/Leu 7+ double marker cells, and a decreased Leu 11+ cell sub-population in patients with active BD, but the majority of Leu 7+ cells in patients with convalescent stage lacked OKT8 antigen when investigated in a double marker system. A parallel increase of Leu 11+ cells was observed in the convalescent stage. This phenotypic analysis was carried out with the NK in vitro functional evaluation of cell populations from peripheral blood. NK cell activity in the clinically active stage of BD was significantly lower than that of healthy controls and patients in the convalescent stage. The decrease of peripheral blood NK function in patients with active BD may be related to the presence of immature forms of NK cells and/or to the increased percentage of T8+/Leu 7+ cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3258201      PMCID: PMC1541639     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  30 in total

1.  Characterization of mucosal antibodies in recurrent aphthous ulceration and Behcet's syndrome.

Authors:  T Lehner
Journal:  Arch Oral Biol       Date:  1969-07       Impact factor: 2.633

2.  Lymphocyte abnormalities in Behçet's syndrome.

Authors:  A M Denman; P J Fialkow; B K Pelton; A C Salo; D J Appleford; C Gilchrist
Journal:  Clin Exp Immunol       Date:  1980-10       Impact factor: 4.330

3.  Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies.

Authors:  J R Ortaldo; S O Sharrow; T Timonen; R B Herberman
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

4.  Phenotypes of human natural killer cell populations detected with monoclonal antibodies.

Authors:  J M Zarling; K A Clouse; W E Biddison; P C Kung
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

5.  Circulating immune complexes in active Behçet's disease.

Authors:  R C Gupta; J D O'Duffy; F C McDuffie; M Meurer; R E Jordon
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

6.  Immune complexes in Behçet's syndrome and recurrent oral ulceration.

Authors:  B D Williams; T Lehner
Journal:  Br Med J       Date:  1977-05-28

7.  Circulating immune complexes in Behçet's syndrome: purification, characterization and cross-reactivity studies.

Authors:  G Valesini; M Picardo; R Pastore; P Pivetti; U Serafini
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

8.  A subset of human cells isolated and characterized by monoclonal antibodies.

Authors:  J Lohmeyer; P Rieber; H Feucht; J Johnson; M Hadam; G Riethmüller
Journal:  Eur J Immunol       Date:  1981-12       Impact factor: 5.532

9.  Functional aberration of T cell subsets in patients with Behçet's disease.

Authors:  T Sakane; H Kotani; S Takada; T Tsunematsu
Journal:  Arthritis Rheum       Date:  1982-11

10.  Cell-mediated immune functions and immunoregulatory cells in Behçet's syndrome.

Authors:  R M Victorino; P Ryan; G R Hughes; H J Hodgson
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

View more
  15 in total

1.  Behçet's disease with a large intracardiac thrombus: a case report.

Authors:  M Baykan; S Celik; C Erdöl; E C Baykan; I Durmus; S Bahadir; H Erdöl; C Orem; H Cakirbay
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

Review 2.  Behçet's disease.

Authors:  V Kontogiannis; R J Powell
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

Review 3.  Pathogenesis of Adamantiades-Behçet's disease.

Authors:  Christos C Zouboulis; Tobias May
Journal:  Med Microbiol Immunol       Date:  2003-03-05       Impact factor: 3.402

Review 4.  Behçet's disease.

Authors:  T Inoue; K Satake
Journal:  Gastroenterol Jpn       Date:  1991-10

5.  Immunopathology of Behçet's disease.

Authors:  R J Powell; S Dunstan
Journal:  Postgrad Med J       Date:  1991-06       Impact factor: 2.401

6.  Cytotoxic T cells against herpes simplex virus in Behçet's disease.

Authors:  K Hamzaoui; A Kahan; K Ayed; M Hamza
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

7.  Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.

Authors:  Pablo Guasp; Elena Lorente; Adrian Martín-Esteban; Eilon Barnea; Paolo Romania; Doriana Fruci; JonasJ W Kuiper; Arie Admon; José A López de Castro
Journal:  Mol Cell Proteomics       Date:  2019-05-15       Impact factor: 5.911

8.  The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.

Authors:  Pablo Guasp; Eilon Barnea; M Francisca González-Escribano; Anaïs Jiménez-Reinoso; José R Regueiro; Arie Admon; José A López de Castro
Journal:  J Biol Chem       Date:  2017-04-26       Impact factor: 5.157

9.  Selenium and Behçet's disease.

Authors:  E Delilbaşi; B Turan; E Yücel; R Saşmaz; A Işimer; A Sayal
Journal:  Biol Trace Elem Res       Date:  1991-01       Impact factor: 3.738

10.  Natural killer cells control a T-helper 1 response in patients with Behçet's disease.

Authors:  Yukie Yamaguchi; Hayato Takahashi; Takashi Satoh; Yuka Okazaki; Nobuhisa Mizuki; Kazuo Takahashi; Zenro Ikezawa; Masataka Kuwana
Journal:  Arthritis Res Ther       Date:  2010-05-11       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.